Multilingual Support:

Concerns

Emphysema/Bronchitis

Do you have emphysema?

Do you have bronchitis?

Do you experience difficulties, beyond breathing, due to your COPD?

Is your COPD stable?

What type of treatment do you receive?

Notice: Object of class WP_Post could not be converted to int in /mnt/ice-mss-dev/wp-includes/post-template.php on line 195 Notice: Object of class WP_Post could not be converted to int in /mnt/ice-mss-dev/wp-includes/post-template.php on line 198

Emphysema/Bronchitis

Emphysema and bronchitis are referred to as chronic obstructive pulmonary disease (COPD).

Do you have emphysema?

Emphysema is caused by injury to the alveolar epithelium, resulting in difficulties during expiration but not during inspiration.

Patients may become “barrel chested” and are referred to as “pink puffers.”

Do you have bronchitis?

Bronchitis is caused by bronchial wall injury due to inflammation and mucus production, resulting in difficulties during inspiration and expiration.

Patients can easily become cyanotic and are referred to as “blue puffers.”

Do you experience difficulties, beyond breathing, due to your COPD?

Patients with COPD are susceptible to developing bacterial pneumonia, pulmonary hypertension, or cor pulmonale (right-sided heart failure).

Is your COPD stable?

Patients without shortness of breath at rest, without a productive cough, and with an oxygen saturation percentage above 91% are considered stabilized.

Alert!

Unstable COPD may be associated with adverse acute events.

What type of treatment do you receive?

There is no cure for COPD. Medications are used to increase bronchodilation and reduce inflammation. Glucocorticosteroids are sometimes used as anti-inflammatory agents.

For stable COPD patients with respiratory symptoms and FEV1 between 60% and 80%: treatment with inhaled bronchodilators may be used.

For stable COPD patients with respiratory symptoms and FEV1 <60%: treatment with inhaled bronchodilators.

For for symptomatic patients with COPD and FEV1 <60%: treatment with monotherapy using either long-acting inhaled anticholinergics or long-acting inhaled ß-agonists.

For symptomatic patients with stable COPD and FEV1 <60%: treatment with combination inhaled therapies (long-acting inhaled anticholinergics,

long-acting inhaled ß-agonists, or inhaled corticosteroids).

For symptomatic patients with FEV1 <50%, or exercise-limited patients with FEV1 >50%: treatment with pulmonary rehabilitation.

For patients with COPD and severe resting hypoxemia (PaO2 <55 mm Hg or SpO2 <88%): treatment with continuous oxygen therapy.

OK